Skip to main content

Eppendorf Licenses Thermal Gradient IP to Analytik Jena


This article was originally published on Jan. 3.

Eppendorf said today that it has licensed patents covering its thermal cycler gradient technology to Analytik Jena, which will use the technology in its thermal cyclers.

Specifically, Eppendorf has licensed to Analytik Jena IP including US Patent Nos. 6,767,512, entitled "Temperature-regulating block with temperature-regulating devices;" and 7,074,367, entitled "Thermostated block with heat-regulating devices."

In the last year, Hamburg, Germany-based Eppendorf has licensed the '512 and '367 patents to a number of life science companies, including Takara Bio (PCR Insider, 11/17/2011), Bulldog Bio (PCR Insider, 9/8/2011), Roche, and Labnet (PCR Insider, 4/7/2011). Eppendorf also uses the technology in its own Mastercycler Pro Gradient, Mastercycler Gradient, and Mastercycler EP Realplex models.

Analytik Jena currently sells two thermal cyclers for endpoint PCR: the FlexCycler for standard PCR and the AlphaSC for rapid PCR; as well as a new platform for real-time PCR, the qTower 2.0.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.